Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson at Barclays Global Consumer Staples Conference Transcript

Sep 05, 2019 / 11:30AM GMT
Release Date Price: €116.88 (+0.36%)
Kristen Marie Stewart;
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everybody. Welcome to another day of the Barclays Consumer Conference. I'm Kristen Stewart. I'm a health care analyst here at Barclays, and it is my pleasure to introduce Johnson & Johnson to open up this morning.

So with me today, I have Thibaut Mongon. He is the Vice -- I'm sorry, Worldwide Chairman of Johnson & Johnson's Consumer Health division. It's about a $14 billion division for Johnson & Johnson. He recently took over. And what I find most impressive is that he has spent 19 years with the company in all 3 of their divisions, so not only Consumer Health but also Medical Devices as well as Pharmaceuticals. He's lived in all kind of 5 different continents, so he really has lived around the globe, has worldwide experience and so he's going to give us a little bit of a presentation. We'll have some time for Q&A here, and then we will continue the Q&A dialogue into the breakout session.

So without further ado, I'll turn it over to Thibaut. Thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot